SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness
Ilaria Cavallari, Ernesto Maddaloni, Annunziata Nusca, Dario Tuccinardi, Raffaella Buzzetti, Paolo Pozzilli, Francesco Grigioni
Topics & Concepts
MedicineIvabradineHeart failureIntensive care medicineTolerabilityValsartanRanolazineCost effectivenessPharmacotherapyInternal medicinePharmacologyAdverse effectHeart rateBlood pressureRisk analysis (engineering)Heart Failure Treatment and ManagementDiabetes Treatment and ManagementHeart rate and cardiovascular health